Briefing: Unlocking the hidden pocket on a billion‑dollar drug target
Strategic angle: Researchers discover new functions of the cereblon protein that could enhance cancer drug efficacy.
Editorial Staff Mar 9
Briefing: Key protein SYFO2 enables 'self-fertilization' of leguminous plants
Strategic angle: Research reveals how SYFO2 protein facilitates self-fertilization in legumes, enhancing agricultural efficiency.
Editorial Staff Mar 9
Briefing: ‘Cash Apples’ is giving away $500,000 to people who click on trees in a web browser
Strategic angle: Want to make real money just by clicking on virtual trees? Starting today, residents of the United States can begin an online hunt for golden apples.
Editorial Staff Mar 9
Briefing: The ER Staffing Conflict and No Facility Fee for a Marmot
Strategic angle: A battle between doctors and a hospital system is an early test of a new law designed to separate business and medicine.
Editorial Staff Mar 9
Briefing: A setback for Roche’s breast cancer drug
Strategic angle: Wall Street's verdict on Prasad, generic semaglutide's new pricing, and other biotech news
Editorial Staff Mar 9
Briefing: Fresh turmoil at the FDA with Prasad’s exit
Strategic angle: Prasad out again, generic Ozempic on its way, and more health news from Morning Rounds
Editorial Staff Mar 9
Briefing: Talkspace to be acquired for $835 million by mental health services giant
Strategic angle: Universal Health Services announces acquisition of virtual mental health company Talkspace.
Editorial Staff Mar 9
Briefing: Health tech company says it will dive into Medicare’s new chronic care experiment
Strategic angle: How a remote patient monitoring company is reworking its tech to enroll in a Medicare program seeking to align payment with health care outcomes.
Editorial Staff Mar 9
Evaluating the Risks of AI Chatbots for Medical Advice
The launch of ChatGPT Health by OpenAI prompts a critical examination of the risks associated with AI-driven health consultations.
Editorial Staff Mar 9
Strategic view: Health advice from chatbots: what to know before using them
Strategic implications in focus: Following OpenAI's recent ChatGPT Health launch, here are key points to consider before relying on AI chatbots for medical guidance.
Editorial Staff Mar 9
Limited Impact of CMS's New Risk-Adjustment Model on Medicare Advantage Benefits
A study in Health Affairs indicates that the new risk-adjustment model from CMS has not substantially altered Medicare Advantage benefits for the 2024-25 period.
Editorial Staff Mar 8
Strategic view: Health Care Workforce, Medicare, And More
Strategic implications in focus: An overview of critical issues in health care as discussed in Health Affairs.
Editorial Staff Mar 8
Strategic view: Practice Pattern Changes After Adoption Of Diagnostic AI Tool Used In Conjunction With Cardiac Imaging
Strategic implications in focus: Health Affairs, Volume 45, Issue 3, Page 238-245, March 2026.
Editorial Staff Mar 8
Disenrollment Rates for Medicare Advantage Beneficiaries Raise Concerns
A recent study indicates that disenrollment rates for Medicare Advantage beneficiaries have tripled between 2017 and 2022, prompting questions about plan stability.
Editorial Staff Mar 8
SSDI Beneficiaries Face Increased Mortality Rates During Medicare Waiting Period
A study spanning 2000 to 2021 reveals concerning mortality trends among SSDI beneficiaries awaiting Medicare, highlighting systemic healthcare risks.
Editorial Staff Mar 8
Staffing Mandates in Nursing Homes: Analyzing Financial and Operational Outcomes
An examination of nursing home staffing mandates from 2010 to 2023 shows increased staffing levels with negligible financial impact and no notable rise in closures.
Editorial Staff Mar 8
Analyzing Labor Unions' Role in Nurse Staffing Ratios and Care Quality
A recent study highlights the complex dynamics between labor unions and nurse staffing ratios in US nursing homes, with implications for care quality.
Editorial Staff Mar 8
Perspective: Stephen Colbert on Kristi Noem: ‘A domestic terrorist who deserves to go to Gitmo’
Executive context: Late-night hosts critique political figures and current events, highlighting Kristi Noem's recent controversies.
Editorial Staff Mar 6
Servier's $2.5 Billion Acquisition of Day One: Strategic Implications
Servier's acquisition of Day One Biopharmaceuticals for $2.5 billion could reshape its position in the pediatric oncology market, but risks remain.
Editorial Staff Mar 6
Strategic view: FDA-UniQure Tussle and Pfizer's Obesity Drug Approval in China
Strategic implications in focus: China has approved a new obesity treatment from Pfizer, heightening competition in a market poised to become even more crowded.
Editorial Staff Mar 6